Optiscan Imaging Limited (ASX:OIL)


right-arrow Created with Sketch. -0.025 (-13.89%)
MCAP $95.97M
Last trade 15.12pm 21/01/2022 20mins delayed

Latest Announcements

20/01/2022OILOptiscan Imaging Limited
20/01/2022OILOptiscan Imaging Limited
20/01/2022 Price SensitivePSOILOptiscan Imaging Limited
20/12/2021OILOptiscan Imaging Limited
20/12/2021OILOptiscan Imaging Limited
15/12/2021OILOptiscan Imaging Limited
15/12/2021OILOptiscan Imaging Limited
13/12/2021OILOptiscan Imaging Limited

Company Overview

Optiscan Imaging Limited is an Australia-based company engaged in the development of microscopic imaging and related technologies for surgery and medical research. The Company has developed and commercialized confocal microscopes for clinical and pre-clinical applications. Its endomicroscopic technology enables 3D, in-vivo imaging of human tissue at the cellular level for cancer screening, diagnoses and in surgery. Its InVivage device is developed for clinical use in the oral cancer and other cancer applications. Its Fluorescence In Vivo Endomicroscopy (FIVE2) also known as ViewnVivo system, is a miniaturised confocal endomicroscope used for cellular level in-vivo imaging in living tissues. The Company also provides customization options for its product, (FIVE2).

OIL in the news

Optiscan Imaging (OIL) Non-Executive Director Camile Farah will step into the role…
Optiscan Imaging (OIL) completes the patient recruitment and imaging component of its…
Optiscan Imaging (OIL) has taken another step forward it its application for…
Optiscan Imaging (OIL) has appointed Robert Cooke as Non-Executive Chair of the…

Search Previous Announcements